Meribank Biotech Co (ROCO:4724) ROE % Adjusted to Book Value : -6.09% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co ROE % Adjusted to Book Value?

Meribank Biotech Co's ROE % for the quarter that ended in Dec. 2023 was -24.55%. Meribank Biotech Co's PB Ratio for the quarter that ended in Dec. 2023 was 4.03. Meribank Biotech Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -6.09%.

Meribank Biotech Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Meribank Biotech Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co ROE % Adjusted to Book Value Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.49

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							-	-	-	-3.60	-6.09

Competitive Comparison of Meribank Biotech Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Meribank Biotech Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meribank Biotech Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Meribank Biotech Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Meribank Biotech Co's ROE % Adjusted to Book Value falls into.

Meribank Biotech Co ROE % Adjusted to Book Value Calculation

Meribank Biotech Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-22.13%	/	4.03
	=	-5.49%

Meribank Biotech Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-24.55%	/	4.03
	=	-6.09%

Meribank Biotech Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines